Skip to content

Medical-device intelligence

GFO: Activated Partial Thromboplastin

FDA product code GFO: Activated Partial Thromboplastin. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
GFO
FDA device name
Activated Partial Thromboplastin
Device class
2
Regulation number
864.7925
Medical specialty
Hematology
Review panel
HE

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore hematology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

52 clearance records and 10 recall records in the covered releases, across 37 source company names and 1 product codes. Dated history runs from Aug 3, 1976 to Jan 9, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202501
December 202501
January 202610
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
GFO · Activated Partial Thromboplastin5210

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

62 matching records
Device / recordCompany in FDA recordSourceSource date
PATHROMTIN SLK955450 · GFOBehring Diagnostics, Inc.510(k)Apr 19, 1996FDA decision date
SYNTHASIL APTT REAGENTK953981 · GFOOrtho Diagnostic Systems, Inc.510(k)Nov 30, 1995FDA decision date
APTT-ESK935169 · GFOHelena Laboratories510(k)Dec 2, 1994FDA decision date
APTT-ES REAGENTK934351 · GFOMedical Diagnostic Technologies, Inc.510(k)Dec 6, 1993FDA decision date
PATHROMTINK932011 · GFOBehring Diagnostics, Inc.510(k)Oct 25, 1993FDA decision date
ACS APCT REAGENT, MODIFIEDK926012 · GFOAnalytical Control Systems, Inc.510(k)Apr 27, 1993FDA decision date
HEMOCHRON CITRA ONESTEP APTT/FAC VI SINGSHOT APTTK924637 · GFOInternational Technidyne Corp.510(k)Jan 27, 1993FDA decision date
HEMOCHRON DIRECT DRAW APTT/FAC VI VACU-APTTK924638 · GFOInternational Technidyne Corp.510(k)Jan 14, 1993FDA decision date
STACLOT LA TEST KITK923731 · GFOAmerican Bioproducts Co.510(k)Dec 23, 1992FDA decision date
PLATELIN LK921396 · GFOOrganon Teknika Corp.510(k)Oct 19, 1992FDA decision date
ACS FREEZE-DRIED APTT REAGENTK921223 · GFOAnalytical Control Systems, Inc.510(k)Aug 18, 1992FDA decision date
ACS APCT REAGENTK921118 · GFOAnalytical Control Systems, Inc.510(k)Jul 28, 1992FDA decision date
ELLAGIC ACID APTT REAGENTK915418 · GFOHelena Laboratories510(k)Feb 14, 1992FDA decision date
HEMOCHRON ONESTEP APTT TESTK915344 · GFOInternational Technidyne Corp.510(k)Feb 11, 1992FDA decision date
HEMOCHRON(R) APTT, MODIFICATIONK911994 · GFOInternational Technidyne Corp.510(k)Jul 17, 1991FDA decision date
ANTICARDIOLIPIN ANTIBODY TEST SYSTEMK903531 · GFOMedical Innovations Corp.510(k)Jan 25, 1991FDA decision date
THE THERATEST ACA TESTK905301 · GFOTheratest Laboratories, Inc.510(k)Jan 14, 1991FDA decision date
APTT REAGENTK904341 · GFOSigma Chemical Co.510(k)Nov 8, 1990FDA decision date
ACS ACTIVATED PARTIAL THROMBOPLASTIN TIME TESTK902556 · GFOAnalytical Control Systems, Inc.510(k)Aug 6, 1990FDA decision date
APTT-EA REAGENT, AN ELLAGIC ACID ACTIVATED REAGENTK900049 · GFOMedical Diagnostic Technologies, Inc.510(k)Jan 25, 1990FDA decision date
ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)K896545 · GFOSigma Chemical Co.510(k)Dec 1, 1989FDA decision date
APTT-P REAGENT, A PARTICLE ACTIVATED REAGENTK895255 · GFOMedical Diagnostic Technologies, Inc.510(k)Oct 6, 1989FDA decision date
APTT BY HEMOCHRON(R)K892209 · GFOIntensive Technology, Inc.510(k)Jun 22, 1989FDA decision date
COAG-1 APTT TEST CARDK891015 · GFOCardiovascular Diagnostic Services510(k)May 22, 1989FDA decision date
EDL GLOBAL ACTIVATED PARTIAL THROMBOPLASTIN TIMEK890859 · GFOElite Diagnostic , Ltd.510(k)Apr 21, 1989FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗